Related references
Note: Only part of the references are listed.The Relationship between AKI and CKD in Patients with Type 2 Diabetes: An Observational Cohort Study
Simona Hapca et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2 V617F mutated platelets
Hagit Hauschner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis
Lukas Ronner et al.
BLOOD (2020)
Thrombosis among 1537 patients with JAK2V617F-mutated myeloproliferative neoplasms: Risk factors and development of a predictive model
Yuhui Zhang et al.
CANCER MEDICINE (2020)
Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera
Ivan Krecak et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis
Marko Lucijanic et al.
ANNALS OF HEMATOLOGY (2020)
Renal complications of primary myelofibrosis
Paolo Strati et al.
LEUKEMIA & LYMPHOMA (2019)
Thromboembolic events in polycythemia vera
Martin Griesshammer et al.
ANNALS OF HEMATOLOGY (2019)
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis
Paolo Strati et al.
ANNALS OF HEMATOLOGY (2019)
Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy
Yasutaka Fukuda et al.
HAEMATOLOGICA (2019)
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
Michele Provenzano et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis
Alessandra Carobbio et al.
BLOOD ADVANCES (2019)
A Case of Essential Thrombocythemia and IgA Nephropathy with Literature Review of the Concurrence
Shoja Rahimian et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2019)
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study
Malin Hultcrantz et al.
ANNALS OF INTERNAL MEDICINE (2018)
Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study
Seung-Woo Baek et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review
Roy O. Mathew et al.
KIDNEY INTERNATIONAL (2017)
JAK inhibition in the treatment of diabetic kidney disease
Frank C. Brosius et al.
DIABETOLOGIA (2016)
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry
A. Kaifie et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Acute Kidney Injury in Diabetes Mellitus
D. Patschan et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2016)
JAK inhibition and progressive kidney disease
Frank C. Brosius et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres
Christian Baer et al.
HAEMATOLOGICA (2015)
Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres
Christian Baer et al.
HAEMATOLOGICA (2015)
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (A-GHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
Stephan Kreher et al.
ANNALS OF HEMATOLOGY (2014)
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Elisa Rumi et al.
BLOOD (2014)
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward
Adeera Levin et al.
KIDNEY INTERNATIONAL (2014)
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease
Ali Tabarroki et al.
LEUKEMIA & LYMPHOMA (2014)
Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms
Alexander Sidelmann Christensen et al.
LEUKEMIA RESEARCH (2014)
Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)
Gregory L. Price et al.
PLOS ONE (2014)
CANCER-ASSOCIATED THROMBOTIC DISEASE Myeloproliferative neoplasms and thrombosis
Tiziano Barbui et al.
BLOOD (2013)
Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups
G. Ocak et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
JAK2 Mutation-Related Disease and Thrombosis
Alessandro M. Vannucchi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146+immunomagnetic enrichmentuflow cytometry and soluble E-selectin detection
Angelo Belotti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
Peter J. Campbell et al.
BLOOD (2012)
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment
Francesco Passamonti et al.
BLOOD (2012)
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
H. Reikvam et al.
LEUKEMIA (2012)
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
Vibe Skov et al.
LEUKEMIA RESEARCH (2012)
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
Alessandra Carobbio et al.
BLOOD (2011)
C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients
Jonathan Bazeley et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Brenda R. Hemmelgarn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden
Eduardo Arellano-Rodrigo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Rapid Kidney Function Decline and Mortality Risk in Older Adults
Dena E. Rifkin et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Aspects of immune dysfunction in end-stage renal disease
Sawako Kato et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Elevated Uric Acid Increases the Risk for Kidney Disease
Rudolf P. Obermayr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
Raffaele Landolfi et al.
BLOOD (2007)
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
K. Yamagata et al.
KIDNEY INTERNATIONAL (2007)
Serum cystatin C as a marker of glomerular filtration rate
Magdalena Madero et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Chronic kidney disease and mortality risk: A systematic review
Marcello Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease
V Menon et al.
KIDNEY INTERNATIONAL (2005)
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
MA Elliott et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
DS Keith et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Share Paper
